We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+6.91%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$535M
AUM Growth
+$28M
Cap. Flow
+$20.7M
Cap. Flow %
3.87%
Top 10 Hldgs %
17.17%
Holding
336
New
30
Increased
83
Reduced
125
Closed
34

Top Buys

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$5.63M
2
MYGN icon
Myriad Genetics
MYGN
+$5.27M
3
AMBA icon
Ambarella
AMBA
+$4.33M
4
EVER icon
EverQuote
EVER
+$3.93M
5
AGX icon
Argan
AGX
+$3.72M

Sector Composition

Rank Sector Weight
1 Industrials 28.91%
2 Technology 24.08%
3 Healthcare 20.66%
4 Financials 5.77%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LINC icon
26
Lincoln Educational Services
LINC
$945M
$5.25M 0.98%
442,249
+21,889
+5% +$239K
TRNS icon
27
Transcat
TRNS
$915M
$5.18M 0.97%
43,273
+5,838
+16% +$689K
SEM
28
DELISTED
Select Medical
SEM
$5.02M 0.94%
265,866
-24,735
-9% -$422K
PRCT icon
29
Procept Biorobotics
PRCT
$1.22B
$4.93M 0.92%
80,764
+20,648
+34% +$1.23M
GMED icon
30
Globus Medical
GMED
$11.5B
$4.79M 0.9%
69,896
-9,024
-11% -$539K
GNRC icon
31
Generac Holdings
GNRC
$13.1B
$4.78M 0.89%
36,174
-2,539
-7% -$351K
DVAX
32
DELISTED
Dynavax Technologies
DVAX
$4.71M 0.88%
419,191
+15,505
+4% +$180K
AMBA icon
33
Ambarella
AMBA
$3.66B
$4.71M 0.88%
+87,219
New +$4.33M
GS icon
34
Goldman Sachs
GS
$302B
$4.63M 0.87%
10,238
-1,179
-10% -$517K
STKL
35
DELISTED
SunOpta
STKL
$4.59M 0.86%
849,492
+20,635
+2% +$121K
WLDN icon
36
Willdan Group
WLDN
$1.29B
$4.48M 0.84%
155,223
+19,887
+15% +$593K
ONT
37
Onterris Inc
ONT
$576M
$4.47M 0.84%
100,347
+12,488
+14% +$562K
LYTS icon
38
LSI Industries
LYTS
$890M
$4.42M 0.83%
305,286
+39,712
+15% +$599K
AGX icon
39
Argan
AGX
$8.02B
$4.15M 0.78%
+56,791
New +$3.72M
PAY icon
40
Paymentus
PAY
$5.08B
$3.98M 0.75%
209,695
+3,145
+2% +$61.6K
ZS icon
41
Zscaler
ZS
$28.7B
$3.95M 0.74%
20,527
-2,033
-9% -$362K
EVER icon
42
EverQuote
EVER
$867M
$3.88M 0.73%
+186,075
New +$3.93M
MRC
43
DELISTED
MRC Global
MRC
$3.86M 0.72%
299,132
+35,559
+13% +$445K
NOVT icon
44
Novanta
NOVT
$6.32B
$3.8M 0.71%
23,299
+3,254
+16% +$528K
MIR icon
45
Mirion Technologies
MIR
$3.79B
$3.76M 0.7%
350,498
+90,998
+35% +$967K
KNSA icon
46
Kiniksa Pharmaceuticals
KNSA
$6.1B
$3.73M 0.7%
199,799
+27,059
+16% +$507K
XOM icon
47
ExxonMobil
XOM
$657B
$3.67M 0.69%
31,919
-3,886
-11% -$453K
TALK icon
48
Talkspace
TALK
$869M
$3.56M 0.67%
1,547,721
+208,227
+16% +$599K
SG icon
49
Sweetgreen
SG
$693M
$3.39M 0.63%
112,333
-5,522
-5% -$151K
GFF icon
50
Griffon
GFF
$4.75B
$3.37M 0.63%
52,711
+13,185
+33% +$892K

Similar funds

Essex Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Essex Investment Management held 336 positions worth $535M, up 5.5% from $507M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Essex Investment Management deployed $20.7M of net new capital in Q2 2024, opening 30 new positions and adding to 83 existing holdings. Its largest new stake was Ligand Pharmaceuticals: 70,780 shares worth $5.96M.

By sector, the portfolio is most concentrated in Industrials at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Aspen Aerogels, an estimated $2.12M trimmed.

  • Essex Investment Management's largest Q2 2024 buy was Ligand Pharmaceuticals: 70,780 shares worth $5.96M.
  • Essex Investment Management added most to AvePoint in Q2 2024, an estimated $3.22M increase.
  • Essex Investment Management's biggest Q2 2024 reduction was Aspen Aerogels, cutting an estimated $2.12M.
  • Essex Investment Management fully exited Digi International in Q2 2024, selling an estimated $7.01M.
  • Essex Investment Management's ten largest holdings make up 17% of its $535M portfolio in Q2 2024.
  • Essex Investment Management opened 30 new positions and closed 34 in Q2 2024.
  • Essex Investment Management's portfolio value rose 5.5% quarter-over-quarter to $535M.

Based on Essex Investment Management's 13F filing for Q2 2024, filed 12 Aug 2024.